Transforming a coronavirus protein into a nanoparticle could be the key to an effective COVID-19 vaccine

 A close-up view of the RBD particle vaccine (green). Credit: Facility for Electron Microscopy Research (FEMR) at McGill University A close-up view of the RBD particle vaccine (green). Credit: Facility for Electron Microscopy Research (FEMR) at McGill University

Transforming a coronavirus protein into a nanoparticle could be the key to an effective COVID-19 vaccine

Researchers from McGill University are part of an international team led by the University of Buffalo, which has discovered a technique that could help increase the effectiveness of vaccines against SARS-CoV-2, the virus that causes COVID-19. The group’s study, titled “SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by Particulate Vaccination,” was published online in the journal Advanced Materials on October 28.

COVID-19 has caused a disruptive global pandemic, infecting at least 40 million and causing more than 1 million deaths worldwide. Since it began spreading in early 2020, biomedical researchers have been in active pursuit of an effective vaccine. Now, researchers suggest that one approach that may be effective is designing vaccines that partially mimic the structure of the virus....

https://publications.mcgill.ca/medenews/2020/10/28/transforming-a-coronavirus-protein-into-a-nanoparticle-could-be-the-key-to-an-effective-covid-19-vaccine/